ZYBT — Zhengye Biotechnology Holding Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual balance sheet for Zhengye Biotechnology Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.006	0.01	0.016
Net Total Accounts Receivable
Net Total Receivables	0.102	0.134	0.099
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.165	0.214	0.206
Net Property, Plant And Equipment	0.255	0.284	0.272
Net Intangible Assets
Other Long Term Assets
Total Assets	0.445	0.52	0.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.126	0.152	0.15
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.178	0.223	0.227
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.267	0.296	0.273
Total Liabilities & Shareholders' Equity	0.445	0.52	0.5
Total Common Shares Outstanding